Improving patient safety by enhancing the medication delivery and administration process into a seamless system that is integrated into the electronic

Phase I efforts were focused on establishing the groundwork for a production-quality medication management system that can be deployed in a clinical setting. Phase II will build upon the Phase I results for the design, development, and deployment of a beta system. The technical objectives for the Phase II research are the following capabilities: (1) Interoperable Framework: Many of the existing vendors offer proprietary and closed clinical information systems which may include some level of data integration with other systems through either unidirectional or bidirectional messaging capabilities. The foundation of the QC-MM system is on interoperability and will be based on open standards and open-source solutions from the ground up. (2) Automation: The key to minimizing errors for a given process is to reduce or eliminate steps that are susceptible to human errors, which can be achieved by replacing them with automated steps. (3) Mobility: The new technology for medication administration needs to inherently be a mobile solution. When new technology is introduced to an existing process, oftentimes the process must conform to adopt the new technology, but the modular nature of QC-MM would allow the solution to conform to the existing process, thus increasing the likelihood of a successful adoption.